Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Gross Margin (2021 - 2025)

PAVmed has reported Gross Margin over the past 5 years, most recently at 867.9% for Q4 2025.

  • For Q4 2025, Gross Margin rose 58210.0% year-over-year to 867.9%; the TTM value through Dec 2025 reached 1027.0%, down 50672.0%, while the annual FY2025 figure was 817.0%, 52879.0% down from the prior year.
  • Gross Margin for Q4 2025 was 867.9% at PAVmed, up from 1000.0% in the prior quarter.
  • Over five years, Gross Margin peaked at 28.0% in Q3 2021 and troughed at 6131.58% in Q3 2022.
  • A 5-year average of 1408.24% and a median of 725.62% in 2025 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: crashed -615958bps in 2022 and later soared 600667bps in 2023.
  • Year by year, Gross Margin stood at 47.0% in 2021, then crashed by -10628bps to 5041.96% in 2022, then soared by 78bps to 1117.73% in 2023, then decreased by -30bps to 1450.0% in 2024, then soared by 40bps to 867.9% in 2025.
  • Business Quant data shows Gross Margin for PAVM at 867.9% in Q4 2025, 1000.0% in Q3 2025, and 583.33% in Q2 2025.